Digital Responsible integration of AI in pharmaceutical labs As applications of generative AI (GenAI), and AI in general, extend to every industry, the dialogue surrounding its responsible integration remains front and centre.
News MorphoSys takeover delivers phase 3 win for Novartis A drug for autoimmune disease Sjögren's syndrome, claimed by Novartis when it bought MorphoSys, could soon be filed for approval.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face